 year review invas aspergillosi necropsi between case invas aspergillosi consecut necropsi incid incid immunosuppress high risk patient case spread lung brain common site increas case second half decad attribut start liver transplant programm liver transplant recipi patient haematolog malign risk aspergillosi kidney transplant recipi solid malign chemotherapi risk haematogen dissemin liver transplant recipi group use high dose steroid anti-reject treatment life case need valu necropsi